Medico Remedies
add_icon

Medico Remedies

52.85
+52.85
(0.00%)
Market Cap
₹- Cr
PE Ratio
-
Volume
4,13,793.00
Day High - Low
₹53.99 - ₹49.96
52W High-Low
₹79.83 - ₹37.18
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
- Cr
EPS
-
PB Ratio
-
Book Value
8.06
EBITDA
-
Dividend Yield
- %
Industry
Healthcare
ROE Growth %
-
Debt to Equity
-
Forecast For
Actual

Company News

View All News
Caret
positive
Medico Remedies Reports Strong Q2 Performance with Revenue Growth and Improved ProfitabilityNov 14, 2025
Medico Remedies Limited reported quarterly revenue of Rs 526.35 lakh and net profit of Rs 356.82 lakh for the quarter ended September 30, 2025, with half-year revenue reaching Rs 932.69 lakh and net profit of Rs 438.63 lakh. The pharmaceutical formulations manufacturer showed significant growth with international sales contributing Rs 467.54 lakh compared to domestic sales of Rs 54.29 lakh in the latest quarter.
positive
Medicore Remedies Receives GMP Compliance Certificate from Ukraine's State Service on Medicines and Drugs ControlNov 14, 2025
Medicore Remedies' Palghar manufacturing facility received GMP compliance certification from Ukraine's State Service on Medicines and Drugs Control on 10 November, 2025, following a successful inspection. The PIC/S certification will enhance the facility's global credibility and facilitate access to regulated markets including Thailand, Singapore, Malaysia, Jordan, and Iraq.
Nov 07, 2025
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
185.27
-
#1 -
-
-
-
-
36.05
942.70
-
#1 -
-
-
-
-
45.40
672.70
-
#1 -
-
-
-
-
30.22
29,240.00
-
#1 -
-
-
-
-
43.51
71.32
-
#1 -
-
-
-
-
46.19
1,604.00
-
#1 -
-
-
-
-
54.09
746.10
-
#1 -
-
-
-
-
46.49
216.12
-
#1 -
-
-
-
-
45.44
1,429.30
-
#1 -
-
-
-
-
56.86
545.60
-
#1 -
-
-
-
-
16.55
Growth Rate
Revenue Growth
-
Net Income Growth
-
Cash Flow Change
-
ROE
-
ROCE
-
EBITDA Margin (Avg.)
-

Yearly Financial Results

Annual Financials
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
Revenue
51
67
55
62
100
91
123
123
144
147
154
176
Expenses
48
63
50
58
95
86
117
114
131
132
136
156
EBITDA
3
4
4
4
5
5
6
9
14
15
18
19
Operating Profit %
6 %
5 %
7 %
6 %
3 %
3 %
4 %
6 %
7 %
9 %
10 %
9 %
Depreciation
1
1
1
1
2
2
2
2
3
3
3
3
Interest
1
1
1
2
1
1
1
1
1
1
1
1
Profit Before Tax
1
2
2
2
2
2
4
7
10
11
14
15
Tax
0
1
0
1
1
1
1
2
3
3
3
4
Net Profit
1
1
2
1
2
2
3
5
7
8
10
11
EPS in ₹
5.91
3.53
5.09
3.65
3.78
3.93
1.56
0.58
0.87
1.00
1.22
1.40

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total Assets
36
46
48
59
76
75
76
77
87
96
120
Fixed Assets
8
7
7
7
12
13
15
18
22
22
21
Current Assets
26
37
38
46
59
57
59
58
65
74
97
Capital Work in Progress
0
0
3
4
1
2
0
0
0
0
0
Investments
0
0
0
0
0
0
1
0
1
2
2
Other Assets
28
39
39
48
63
60
59
59
64
73
97
Total Liabilities
36
46
48
59
76
75
76
77
87
96
120
Current Liabilities
22
26
21
30
45
41
38
38
42
43
57
Non Current Liabilities
1
4
11
3
3
5
5
3
2
1
0
Total Equity
14
15
16
27
28
30
33
37
44
52
63
Reserve & Surplus
12
13
13
23
24
26
28
20
27
36
46
Share Capital
2
2
3
4
4
4
4
17
17
17
17

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Net Cash Flow
1
-1
-0
-1
0
1
-10
-2
-0
-1
1
Investing Activities
-2
0
-3
-5
-4
-3
-17
-2
-7
-3
-4
Operating Activities
-0
-4
-3
5
5
1
-11
6
8
2
5
Financing Activities
3
2
6
-1
-1
3
18
-6
-2
-1
-1

Share Holding

% Holding
Mar 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Jul 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Promoter
73.34 %
73.34 %
73.34 %
73.34 %
73.34 %
73.34 %
73.34 %
73.34 %
73.34 %
73.34 %
73.34 %
73.34 %
73.34 %
73.34 %
73.34 %
66.83 %
63.79 %
62.59 %
61.38 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
1.12 %
0.00 %
0.29 %
0.23 %
0.22 %
0.39 %
0.12 %
0.07 %
0.30 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.74 %
0.97 %
0.97 %
0.78 %
0.01 %
0.01 %
0.01 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
8.18 %
6.79 %
7.18 %
7.08 %
7.13 %
7.08 %
8.57 %
11.27 %
12.20 %
13.52 %
13.21 %
14.64 %
14.39 %
17.49 %
17.66 %
18.08 %
22.13 %
22.79 %
23.11 %
Others
18.48 %
19.87 %
19.48 %
19.58 %
19.53 %
19.58 %
18.09 %
15.39 %
14.46 %
13.15 %
12.34 %
12.02 %
11.24 %
7.98 %
7.81 %
13.92 %
13.94 %
14.53 %
15.19 %
No of Share Holders
107
89
120
119
501
119
778
1,777
2,783
5,055
5,264
6,052
10,685
12,902
12,887
14,104
15,424
16,474
18,503

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
17 Nov 2021 BONUS Bonus
3:1
16 Nov 2021 25.50 23.51
02 Feb 2023 SPLIT Split
2:10
16 Mar 2023 62.60 62.60
05 Sept 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
05 Sept 2024 37.99 45.90
12 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
12 Nov 2024 58.59 60.96
05 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
05 Feb 2025 73.52 74.88
08 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
08 May 2025 56.52 53.22
08 Aug 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
08 Aug 2025 40.19 38.58
08 Sept 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
08 Sept 2025 39.57 39.47
14 Nov 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
14 Nov 2025 49.44 53.19

Announcements

Board Meeting Outcome for OutcomeNov 14, 2025
Disclosure Under Regulation 30 Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015- Issuance Of GMP Compliance Certificate By The State Service Of Ukraine On Medicines And Drugs ControlNov 14, 2025
Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_OrderNov 07, 2025
Board Meeting Intimation for Approval Of Unaudited Financial Results For The Quarter Ended 30Th September 2025Nov 06, 2025
Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_OrderOct 06, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Sep 27, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Sep 27, 2025
Closure of Trading WindowSep 26, 2025
Intimation Of Action Taken Or Order Passed By Regulatory Statutory Enforcement Authority Or Judicial Body Under Regulation 30 (Read With Part B Of Schedule III) (Listing Obligations And Disclosure Requirements) Regulations 2015 ("Listing Regulations)Sep 24, 2025
Shareholder Meeting / Postal Ballot-Outcome of AGMSep 08, 2025
Dispatch Of Letter To Shareholders With Web-Link Of Notice Of AGM And Annual Report 2024-25Sep 03, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 11, 2025
Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance OfficerAug 08, 2025
Financial Results For June 2025Aug 08, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held TodayAug 08, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 06, 2025
Intimation For Book ClosureAug 05, 2025
31St AGM Of Medico Remedies Limited To Be Held On Monday 8Th September 2025 At 4.00 PM Through VC/OAVMAug 05, 2025
Reg. 34 (1) Annual Report.Aug 05, 2025
Board Meeting Intimation for Approval Of Results For The Quarter Ended 30Th June 2025.Aug 01, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 01, 2025
Outcome Of Board Meeting Held TodayJul 30, 2025
Announcement under Regulation 30 (LODR)-Change in DirectorateJul 30, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held TodayJul 30, 2025
Closure of Trading WindowJun 26, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Jun 23, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Jun 23, 2025
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 30, 2025
Intimation For Commencement Of Work For New Factory Under Regulation 30 (Read With Part B Of Schedule III) (Listing Obligations And Disclosure Requirements) Regulations 2015 ("Listing Regulations)May 15, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 10, 2025
Appointment Of Secretarial Auditor & Approval Of Directors Report Alongwith AnnexuresMay 08, 2025
Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/sMay 08, 2025
Financial Results For March 2025May 08, 2025
Announcement under Regulation 30 (LODR)-CessationMay 08, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held TodayMay 08, 2025
Board Meeting Intimation for Approval Of Financial Results For March 2025Apr 30, 2025
Announcement under Regulation 30 (LODR)-Resignation of DirectorApr 09, 2025
Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_OrderApr 08, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Apr 03, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Apr 02, 2025
Closure of Trading WindowMar 27, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Mar 11, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Mar 08, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Mar 07, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Mar 05, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Feb 20, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Feb 20, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Feb 19, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Feb 19, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 07, 2025

Technical Indicators